About the Prostate Cancer Foundation
PCF’s mission is to accelerate the world’s most promising prostate cancer research for better treatments and cures.
The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised nearly $660 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.
The Reliable Source for the Latest Developments
For the men and their families fighting prostate cancer globally, PCF is a primary source for new standard-of-care and research information. We connect patients, loved ones, care providers and scientists to critical updates, the latest developments, best practices and news from the treatment pipeline.
Advancing Hope, with Your Help
Many important discoveries in the fight against prostate cancer since 1993 resulted from PCF funding or coordination—including the development of new medications, gene therapy approaches and the development of vaccines that may soon work with the body’s immune system to kill prostate cancer cells.
Thanks to these and other victories, the U.S. death rate from prostate cancer has dropped nearly 40% from what was once projected. But much more work remains—and we must intensify our efforts now. Too many men still die from prostate cancer; too many families still suffer.